1. Home
  2. NTRA vs MTD Comparison

NTRA vs MTD Comparison

Compare NTRA & MTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • MTD
  • Stock Information
  • Founded
  • NTRA 2003
  • MTD 1991
  • Country
  • NTRA United States
  • MTD United States
  • Employees
  • NTRA N/A
  • MTD N/A
  • Industry
  • NTRA Medical Specialities
  • MTD Biotechnology: Laboratory Analytical Instruments
  • Sector
  • NTRA Health Care
  • MTD Industrials
  • Exchange
  • NTRA Nasdaq
  • MTD Nasdaq
  • Market Cap
  • NTRA 20.9B
  • MTD 22.4B
  • IPO Year
  • NTRA 2015
  • MTD 1997
  • Fundamental
  • Price
  • NTRA $151.95
  • MTD $1,080.29
  • Analyst Decision
  • NTRA Strong Buy
  • MTD Buy
  • Analyst Count
  • NTRA 17
  • MTD 8
  • Target Price
  • NTRA $178.41
  • MTD $1,294.88
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • MTD 227.6K
  • Earning Date
  • NTRA 05-08-2025
  • MTD 05-01-2025
  • Dividend Yield
  • NTRA N/A
  • MTD N/A
  • EPS Growth
  • NTRA N/A
  • MTD 12.38
  • EPS
  • NTRA N/A
  • MTD 40.11
  • Revenue
  • NTRA $1,831,000,000.00
  • MTD $3,830,156,000.00
  • Revenue This Year
  • NTRA $15.45
  • MTD $2.29
  • Revenue Next Year
  • NTRA $18.43
  • MTD $5.35
  • P/E Ratio
  • NTRA N/A
  • MTD $27.12
  • Revenue Growth
  • NTRA 51.50
  • MTD 1.18
  • 52 Week Low
  • NTRA $92.14
  • MTD $946.69
  • 52 Week High
  • NTRA $183.00
  • MTD $1,546.93
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 49.96
  • MTD 49.22
  • Support Level
  • NTRA $153.40
  • MTD $1,052.05
  • Resistance Level
  • NTRA $159.15
  • MTD $1,123.57
  • Average True Range (ATR)
  • NTRA 6.36
  • MTD 40.88
  • MACD
  • NTRA 0.65
  • MTD 11.10
  • Stochastic Oscillator
  • NTRA 39.44
  • MTD 66.92

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About MTD Mettler-Toledo International Inc.

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.

Share on Social Networks: